Superior Gluteal Neuropathy -Total Hip Arthroplasty
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03492684 |
|
Recruitment Status : Unknown
Verified April 2018 by Mohamed Hamed Mohamed, Assiut University.
Recruitment status was: Not yet recruiting
First Posted : April 10, 2018
Last Update Posted : April 10, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment |
|---|---|
| ElectroPhys: Mononeuropathy | Procedure: total hip arthroplasty |
Neurological complications following total hip arthroplasty are uncommon, and their impact ranges from transient and trivial to permanent and devastating.
In general, the prevalence rate of neurologic injury after primary hip arthroplasty is estimated as 0.7-3.5% , whereas it may increase up to 7.6% after revision hip arthroplasty.
Direct or indirect injuries of nerves may occur during operative exposure and subsequent procedures. Injuries to the peripheral nerves can come about in several ways: laceration, ischemia, mechanical deformation from compression or distraction, or a combination of these causes.
Peripheral nerve injuries can involve either distant sites or nerves in the immediate vicinity of the hip joint. Sciatic nerve injury is the most common nerve to be injured following total hip arthroplasty. Femoral nerve injury is much less common and is associated with an anterior approach. Its diagnosis is often delayed, but the prognosis is generally better than with sciatic nerve injury.
The direct lateral approach to the hip was described by Hardinge and is based on the observation that the gluteus medius and vastus lateralis are in functional continuity through the thick tendinous periosteum covering the greater trochanter.
This approach involves splitting the gluteus medius and retracting a portion of the muscle anteriorly in continuity with part of the vastus lateralis. It avoids trochanteric osteotomy, but the neurovascular supply of gluteus medius and tensor fascia lata is vulnerable.
The superior gluteal nerve may be compromised during total hip arthroplasty done through the direct lateral approach of Hardinge which puts this nerve at risk when the gluteus medius is split and retracted anteriorly.
The function of the abductors may be impaired after operation if there is damage to the superior gluteal nerve or if the muscle flap is reattached inadequately to the trochanter.
| Study Type : | Observational |
| Estimated Enrollment : | 50 participants |
| Observational Model: | Case-Only |
| Time Perspective: | Prospective |
| Official Title: | Study of Superior Gluteal Mononeuropathy After Total Hip Arthroplasty Through Modified Direct Lateral Approach |
| Estimated Study Start Date : | September 1, 2018 |
| Estimated Primary Completion Date : | September 1, 2019 |
| Estimated Study Completion Date : | September 1, 2019 |
- Procedure: total hip arthroplasty
total hip arthroplasty and EMGOther Name: electrophysiological study
- Number of participants with failure of initial intervention [ Time Frame: one year ]prospective case series study study of Superior gluteal mononeuropathy after total hip arthroplasty through modified direct lateral approach by EMG studies
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 80 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Sampling Method: | Non-Probability Sample |
- Age: adults
- Sex: both males and female
- Operation: unilateral primary total hip replacement.
Inclusion Criteria:
- Age: adults
- Sex: both males and female
- Operation: unilateral primary total hip replacement
Exclusion Criteria:
- Patient refusal
- Patients with pre-existing neuromuscular abnormality
- Preoperative immobility
- patient with bilateral total hip arthroplasty or hip pathology
- Revision hip arthroplasty
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03492684
| Contact: Mohamed hamed mohamed | +0201146962067 | dr.mohamedelhamed@gmail.com |
| Principal Investigator: | mohamed hamed mohamed | Assiut University |
| Responsible Party: | Mohamed Hamed Mohamed, DR.mohamed hamed, Assiut University |
| ClinicalTrials.gov Identifier: | NCT03492684 |
| Other Study ID Numbers: |
neuropathy - hip arthroplasty |
| First Posted: | April 10, 2018 Key Record Dates |
| Last Update Posted: | April 10, 2018 |
| Last Verified: | April 2018 |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
nerve injury after total hip arthroplasty |
|
Mononeuropathies Peripheral Nervous System Diseases Neuromuscular Diseases Nervous System Diseases |

